<?xml version="1.0" ?>
<document id="0cd96fd42139b22b63e5752eda2c38990a18763a">
  <chunk id="0cd96fd42139b22b63e5752eda2c38990a18763a.c0" text="Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells">
    <entity charOffset="28-34" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c0.e0" ontology_id="HP_0002664" text="Cancer" type="phenotype"/>
  </chunk>
  <chunk id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1" text="CD133 (prominin-1), a 5-transmembrane glycoprotein, has recently been considered to be an important marker that represents the subset population of cancer stem-like cells. Herein we report the isolation of CD133-positive cells (LC-CD133 + ) and CD133-negative cells (LC-CD133 2 ) from tissue samples of ten patients with non-small cell lung cancer (LC) and five LC cell lines. LC-CD133 + displayed higher Oct-4 expressions with the ability to self-renew and may represent a reservoir with proliferative potential for generating lung cancer cells. Furthermore, LC-CD133 + , unlike LC-CD133 2 , highly coexpressed the multiple drug-resistant marker ABCG2 and showed significant resistance to chemotherapy agents (i.e., cisplatin, etoposide, doxorubicin, and paclitaxel) and radiotherapy. The treatment of Oct-4 siRNA with lentiviral vector can specifically block the capability of LC-CD133 + to form spheres and can further facilitate LC-CD133 + to differentiate into LC-CD133 2 . In addition, knock-down of Oct-4 expression in LC-CD133 + can significantly inhibit the abilities of tumor invasion and colony formation, and increase apoptotic activities of caspase 3 and poly (ADP-ribose) polymerase (PARP). Finally, in vitro and in vivo studies further confirm that the treatment effect of chemoradiotherapy for LC-CD133 + can be improved by the treatment of Oct-4 siRNA. In conclusion, we demonstrated that Oct-4 expression plays a crucial role in maintaining the self-renewing, cancer stem-like, and chemoradioresistant properties of LC-CD133 + . Future research is warranted regarding the up-regulated expression of Oct-4 in LC-CD133 + and malignant lung cancer.">
    <entity charOffset="148-154" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1.e0" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="321-347" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1.e1" ontology_id="HP_0030358" text="non-small cell lung cancer" type="phenotype"/>
    <entity charOffset="341-347" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1.e2" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="533-539" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1.e3" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1080-1085" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1.e4" ontology_id="HP_0002664" text="tumor" type="phenotype"/>
    <entity charOffset="1478-1484" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1.e5" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1656-1662" id="0cd96fd42139b22b63e5752eda2c38990a18763a.c1.e6" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
  </chunk>
</document>
